The association between blood pressure (BP) and dementia is not easily interpreted, but some prospective studies suggest that dementia may lower BP.
Results: Systolic BP increased with time in the unimpaired participants, and increased less in women who developed cognitive impairment and in women who developed dementia. Diastolic BP declined significantly (PϽ.001) with time in all 3 groups. Compared with unimpaired women, the adjusted rate of decline in diastolic BP was significantly (P = .04) greater for the women who developed dementia.
Conclusions:
These findings are consistent with previous findings that the relationship between BP and dementia is affected by age at data collection. Valid inferences about the effect of BP on the development of dementia require prospective data collection in which subjects are free of dementia or cognitive impairment at enrollment.
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E PIDEMIOLOGIC STUDIES OF THE association between blood pressure (BP) and dementia are not easily interpreted. 1 Cross-sectional studies are susceptible to several biases. The results of prospective studies are mixed. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In an analysis of cross-sectional data from a study of dementia in women, we found a lower risk of all dementia and dementia without known cause (probable Alzheimer disease) in women who reported hypertension. 12 We took advantage of the availability of medical records for the decade before this cross-sectional assessment to examine the pattern of BP before the time when women were classified as having dementia to explore further the relationship between BP and dementia.
METHODS
This study was reviewed and approved by the Kaiser Permanente Southern California Institutional Review Board.
SUBJECTS
The starting point for identification of subjects was the Women's Memory Study, a prospective study whose primary aim is to assess the relationship between hormone therapy (HT) and dementia and Alzheimer disease. Details of recruitment to the study have been published. 12 Assembly of the Women's Memory Study cohort involved use of computer-stored prescription data from the Kaiser Permanente Southern California Pharmacy Information Management System to identify women 75 years and older on July 1, 1998, who had at least 1 prescription for oral estrogen filled in a Kaiser Permanente Southern California pharmacy in every calendar year from January 1, 1992, to July 1, 1998 (current HT users) and a comparison group of non-HT users, who were women 75 years and older on July 1, 1998, who did not have prescriptions for estrogen during the same period. Of the 6542 women asked to participate in the study (2930 HT users and 3612 HT nonusers), 3924 (1944 HT users and 1980 HT nonusers) enrolled.
These women, or their proxies, provided demographic and health history information in a baseline interview. Participants were clas-sified as having dementia, cognitive impairment without dementia, or no impairment based on a multistage testing strategy. This involved use of the Telephone Interview for Cognitive Status-modified, 13, 14 administered at the baseline interview; the Telephone Dementia Questionnaire, 15 which was administered to a proxy; and medical record review.
BP SUBSTUDY
The data reported herein derive from a substudy that was conceived after completion of enrollment into the Women's Memory Study. The substudy involved review of the Kaiser Permanente outpatient medical records of a sample of the Women's Memory Study participants. The substudy participants included all women classified at the baseline assessment as having dementia (n=300) or cognitive impairment (n=285), along with an equal comparison group of women who, at baseline, were classified as cognitively unimpaired (n=585). The unimpaired subjects were selected at random from among all women classified as cognitively unimpaired at the baseline assessment (n=3339).
The medical record review covered the period from 10 years before the baseline interview to the day of the baseline interview. The 10-year span began January 15, 1989 , and ended September 30, 1999, depending on baseline interview date. For each year before baseline, data were abstracted on up to 3 BP measurements from among all BP measurements recorded in the outpatient medical record. Of the 1133 patients with data available for analysis, 225 (19.9%) had up to 3 BP measurements and 837 (73.9%) had at least 2 BP measurements each year. When more than 3 measurements were available, 3 were selected to span the full year. From 1989 to 1999, measurement of BP at adult primary care visits was a routine procedure. Blood pressure was generally measured with mercury manometers. Cuffs of different sizes were variably available, and there was no standard protocol for cuff size choice. There was no special training in BP measurement.
For each woman whose records were included, the mean BP in the calendar year before the baseline interview and in each of the 9 years before the baseline interview was calculated. The grand mean BP in the dementia status groups (dementia, cognitive impairment, and unimpaired) was then calculated for each year before the baseline interview.
A BP measurement was considered invalid if the recorded systolic BP (SBP) was lower than the diastolic BP (DBP), if the DBP was less than 10 points lower than the SBP, or if the SBP was higher than 300 mm Hg. Invalid BP measurements were excluded.
ANALYSIS
The statistical significance of differences in the characteristics of women by dementia classification was tested using the 2 statistic.
To determine whether the change over time differed among the dementia classification groups, we performed a repeatedmeasures analysis of covariance with mean BP over time as the repeated outcome variable. This model was fitted using dementia group, year before the dementia diagnosis, and an interaction term for dementia classification and year, adjusting for age at interview. Separate models were constructed for systolic and diastolic measurements. A procedure (MIXED) with a statement (REPEATED) in the 1999 version of SAS statistical software (SAS Institute Inc, Cary, NC) was used to fit the repeated-measures data. Least squares means estimates of SBP and DBP in the 3 dementia classification groups based on repeated-measures analysis of covariance were conducted. Differences were statistically signficant at PϽ.05 (2-tailed).
RESULTS
A total of 1170 women were identified for inclusion in the substudy. The outpatient medical records of 18 women could not be located, and the medical records of 19 women had no BP values recorded during the 10-year span. This left 1133 women for the analysis. Table 1 shows selected characteristics of women whose records were included according to classification as having dementia, having cognitive impairment, or being unimpaired at the 1999 assessment. Compared with unimpaired women, those with dementia were older. The mean (SD) ages of the 3 groups (unimpaired women, those with cognitive impairment, and those with dementia) were 78.6 (3.3), 79.9 (3.8), and 81.0 (4.5) years, respectively. The age difference among the 3 groups was significant (PϽ.001). Those with dementia had less education, and were more likely to have a history of stroke, myocardial infarction, Parkinson disease, or diabetes mellitus. A lower percentage of women with dementia had a history of hypertension, as previously reported. 12 Of the women in the analysis, 55.9% had at least 1 BP measurement recorded in each of the 10 years of data abstraction; 92.5% had at least 1 reading for at least 5 of the 10 years. In no year was there less than 81.4% of the women in the analysis with at least 1 BP measurement. Of the 25850 documented BP measurements recorded during data abstraction, 9 were excluded because they were invalid. Table 2 shows the unadjusted mean BP 9 and 5 years before assessment and in the year of the assessment by dementia classification at assessment. Nine years before the assessment, the mean (SD) SBP was slightly higher for women who developed dementia compared with women who remained unimpaired. At assessment, the mean (SD) SBP in women who developed dementia was lower than in women who remained unimpaired. Figure 1 and Figure 2 show least squares means estimates of SBP and DBP, respectively, and can be viewed as a reconstruction of longitudinal measures of BP in a cohort oversampled to include women who developed dementia or cognitive impairment. The adjusted SBP increased with time in the unimpaired women (Figure 1) . The adjusted SBP increased less in the women who developed cognitive impairment and in the women who developed dementia. The difference in the adjusted rate of change over time in SBP between the women who developed dementia and the unimpaired women was statistically significant (P Ͻ.001). The difference in the adjusted rate of change in SBP between the cognitively impaired women and the unimpaired women was of marginal significance (P =.04). The difference between the women who developed dementia and those who were cognitively impaired was not significant (P=.07). The effect of time on SBP was statistically significant in the unimpaired women and in the cognitively impaired women (P Ͻ .001 for both), but only marginally significant (P=.04) in the women who developed dementia.
In comparable multivariate analyses of DBP (Figure 2 ), the adjusted rate of decline in DBP was marginally significantly greater for the women who developed dementia (P=.04) compared with the unimpaired women. The dif- ference between the unimpaired women and the women who were cognitively impaired was not significant (P=.33).
The difference between the women who developed dementia and those who were cognitively impaired also was not significant (P = .37). Diastolic BP declined significantly with time in all 3 groups (PϽ.001 for all).
COMMENT
In our study, SBP increased less over time in women who developed dementia than in women who remained unimpaired. Diastolic BP declined in women who developed dementia and in those who remained unimpaired, but it declined less in women who remained unimpaired. The results suggest that dementia modifies the effect of aging on BP. Our findings are consistent with those of Skoog et al, 4 who reported on 15 years of follow-up in 382 individuals without dementia who were enrolled in the Swedish Longitudinal Population Study. At enrollment into that study at the age of 70 years, individuals who later developed dementia had higher SBP (178 vs 164 mm Hg) and DBP (101 vs 92 mm Hg) val- *Data are given as number (percentage) of each group. Some percentages may not add up to 100 because some people will have more than 1 medical condition.
†Comparing the 3 classification groups. ues. However, there was no BP difference between individuals with dementia and those without dementia at the end of the 15-year follow-up.
Burke et al 16 reported that preclinical dementia is associated with pathologic changes that cause BP dysregulation. This provides a mechanistic explanation for our observations. We hypothesize that pathologic neural changes affect the slope of BP change and the development of dementia.
Our findings explain the lower odds ratio for dementia in women who reported hypertension at enrollment into our study: either clinical hypertension did not develop or clinical hypertension resolved. This phenomenon may provide an explanation for some of the contradictory and confusing findings in other cross-sectional studies and in casecontrol studies.
Several studies suggest that an elevated BP measured in midlife increases the risk of dementia or accelerates age-related cognitive decline. Mechanistic explanations are abundant. [17] [18] [19] [20] [21] Our study does not rule out a relationship between hypertension, especially uncontrolled hypertension in midlife, and the development of dementia. 5, 6, 10 High and low BP in midlife may affect dementia risk. In the Kungsholmen Project, for example, severe uncontrolled hypertension increased the risk for all dementia, and BP below a certain level (SBP, Յ140 mm Hg; or DBP, Յ75 mm Hg) also increased the risk for Alzheimer disease and all dementia. 10 We attempted to use our data to explain the relationship between dementia and BP classified in categories (optimal BP, healthy BP, mild hypertension, moderate or severe hypertension, and isolated systolic hypertension). Because BP category changed over time and was related to antihypertensive treatment, we could not identify their separate effects.
Our study and the analysis have limitations. Mortality due to the complications of hypertension in midlife may have biased BP among those who survived to enroll into the study. Our analysis did not directly measure person-specific paths of change in BP nor did it control for baseline BP. The study population comprised women who were almost exclusively white, were all long-term enrollees in a single health plan, and were more likely than elderly women in the general population to use HT.
Our results have methodologic implications. They suggest that valid inferences about the effect of BP on the development of dementia will require prospective data collection in which subjects are free of dementia and cognitive impairment at study enrollment. Studies will need to enroll subjects at ages when dementia has not affected BP. 
